Healthcare provider profile · identity verified

Victor Cabezudo, ARNP

Nurse Practitioner · HOWEY IN THE HILLS, FL · NPI 1295738607

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	674	97
Atorvastatin Calcium	Atorvastatin Calcium	606	102
Pantoprazole Sodium	Pantoprazole Sodium	567	84
Donepezil Hcl	Donepezil Hcl	526	74
Amlodipine Besylate	Amlodipine Besylate	513	78
Quetiapine Fumarate	Quetiapine Fumarate	509	61
Furosemide	Furosemide	475	75
Potassium Chloride	Potassium Chloride	359	56
Trazodone Hcl	Trazodone Hcl	342	46
Lisinopril	Lisinopril	326	48
Mirtazapine	Mirtazapine	322	48
Sertraline Hcl	Sertraline Hcl	322	48
Memantine Hcl	Memantine Hcl	317	46
Eliquis	Apixaban	309	48
Losartan Potassium	Losartan Potassium	293	48
Escitalopram Oxalate	Escitalopram Oxalate	284	41
Rosuvastatin Calcium	Rosuvastatin Calcium	277	39
Metoprolol Succinate	Metoprolol Succinate	246	46
Metoprolol Tartrate	Metoprolol Tartrate	232	34
Omeprazole	Omeprazole	228	32
Tamsulosin Hcl	Tamsulosin Hcl	226	42
Clopidogrel	Clopidogrel Bisulfate	211	29
Simvastatin	Simvastatin	209	30
Carvedilol	Carvedilol	178	24
Metformin Hcl	Metformin Hcl	162	29
Famotidine	Famotidine	153	33
Finasteride	Finasteride	125	24
Gabapentin	Gabapentin	124	23
Hydrochlorothiazide	Hydrochlorothiazide	99	16
Montelukast Sodium	Montelukast Sodium	99	11
Divalproex Sodium	Divalproex Sodium	92	17
Latanoprost	Latanoprost	90	23
Lorazepam	Lorazepam	89	12
Alprazolam	Alprazolam	86	27
Carbidopa-Levodopa	Carbidopa/Levodopa	86	12
Cephalexin	Cephalexin	86	65
Citalopram Hbr	Citalopram Hydrobromide	86	15
Xarelto	Rivaroxaban	86	12
Prednisone	Prednisone	82	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	81	66
Buspirone Hcl	Buspirone Hcl	80	16
Glimepiride	Glimepiride	79	11
Fluticasone Propionate	Fluticasone Propionate	78	18
Glipizide	Glipizide	76	suppressed
Alendronate Sodium	Alendronate Sodium	71	suppressed
Pravastatin Sodium	Pravastatin Sodium	70	11
Levetiracetam	Levetiracetam	69	13
Tramadol Hcl	Tramadol Hcl	67	20
Meloxicam	Meloxicam	66	suppressed
Atenolol	Atenolol	63	12
Hydralazine Hcl	Hydralazine Hcl	63	11
Midodrine Hcl	Midodrine Hcl	59	12
Rivastigmine	Rivastigmine	57	suppressed
Spironolactone	Spironolactone	55	suppressed
Allopurinol	Allopurinol	54	suppressed
Nifedipine Er	Nifedipine	51	suppressed
Clonazepam	Clonazepam	50	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	47	suppressed
Risperidone	Risperidone	47	suppressed
Azithromycin	Azithromycin	44	40
Memantine Hcl Er	Memantine Hcl	43	suppressed
Amiodarone Hcl	Amiodarone Hcl	42	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	suppressed
Valsartan	Valsartan	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	suppressed
Metformin Hcl Er	Metformin Hcl	40	suppressed
Duloxetine Hcl	Duloxetine Hcl	39	suppressed
Torsemide	Torsemide	39	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	38	25
Oxybutynin Chloride Er	Oxybutynin Chloride	37	suppressed
Myrbetriq	Mirabegron	36	suppressed
Solifenacin Succinate	Solifenacin Succinate	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	34	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	34	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Entresto	Sacubitril/Valsartan	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Ramipril	Ramipril	32	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Januvia	Sitagliptin Phosphate	31	suppressed
Methenamine Hippurate	Methenamine Hippurate	31	suppressed
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Timolol Maleate	Timolol Maleate	31	suppressed
Nystatin	Nystatin	30	20
Permethrin	Permethrin	30	26
Bumetanide	Bumetanide	29	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	29	27
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	13
Alcohol Swabs	Alcohol Antiseptic Pads	27	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	24	22
Lovastatin	Lovastatin	24	suppressed
Topiramate	Topiramate	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Levofloxacin	Levofloxacin	23	21
Methimazole	Methimazole	23	suppressed
Temazepam	Temazepam	23	suppressed
Olanzapine	Olanzapine	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Cefdinir	Cefdinir	21	20
Enalapril Maleate	Enalapril Maleate	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Erythromycin	Erythromycin Base	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	20	suppressed
Methylprednisolone	Methylprednisolone	20	19
Trospium Chloride	Trospium Chloride	20	suppressed
Galantamine Er	Galantamine Hbr	19	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Synthroid	Levothyroxine Sodium	19	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	18	suppressed
Digoxin	Digoxin	18	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	16	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	14
Primidone	Primidone	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Carbamazepine	Carbamazepine	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Entacapone	Entacapone	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Nyamyc	Nystatin	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	13	suppressed
Dutasteride	Dutasteride	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Insulin Aspart Prot Mix 70-30	Insulin Aspart Prot/Insuln Asp	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Multaq	Dronedarone Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Dexamethasone	Dexamethasone	12	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Lactulose	Lactulose	12	suppressed
Lumigan	Bimatoprost	12	suppressed
Rytary	Carbidopa/Levodopa	12	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	12	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error